Eiko Lifesciences - Quaterly Results

The topline stands at Rs. 141.78 millions for the June 2026 quarter. The mentioned figure indicates a rise of about 90.26% as against Rs. 74.52 millions during the year-ago period.Net profit for the quarter ended June 2026 increased significantly by 53.68% to Rs. 10.65 millions from Rs. 6.93 millions.The company reported a good operating profit of 15.93 millions compared to 10.74 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	141.78	74.52	90.26	141.78	74.52	90.26	421.27	324.92	29.65
Other Income	6.83	5.54	23.29	6.83	5.54	23.29	21.29	10.24	107.91
PBIDT	15.93	10.74	48.32	15.93	10.74	48.32	54.66	27.33	100.00
Interest	0.41	0.18	127.78	0.41	0.18	127.78	1.63	1.27	28.35
PBDT	15.52	10.56	46.97	15.52	10.56	46.97	53.03	29.47	79.95
Depreciation	1.47	1.48	-0.68	1.47	1.48	-0.68	5.90	6.29	-6.20
PBT	14.05	9.08	54.74	14.05	9.08	54.74	47.13	23.18	103.32
TAX	3.40	2.15	58.14	3.40	2.15	58.14	11.31	5.77	96.01
Deferred Tax	0.14	0.16	-12.50	0.14	0.16	-12.50	0.82	1.23	-33.33
PAT	10.65	6.93	53.68	10.65	6.93	53.68	35.82	17.41	105.74
Equity	143.46	137.63	4.24	143.46	137.63	4.24	143.46	137.63	4.24
PBIDTM(%)	11.24	14.41	-22.04	11.24	14.41	-22.04	12.98	8.41	54.26